RxDoctor Payments Data

Melanie Johnson

Family · Wilmington, OHNPI 1649602137

Payments from drug & device makers

$4,199in general payments, 2019–2025

Across 307 payments — averaging $13.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$878
  • Lilly USA, LLC$511
  • Novo Nordisk$362
  • AstraZeneca$361
  • Boehringer Ingelheim$239
  • Takeda Pharmaceuticals U.S.A., Inc.$197
  • plus $2K from 21 others

What the payments were for

  • Food & beverage$4,180100%
  • Education$190%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,199 in reported general payments places this provider in the 90th percentile of 6,812 family providers in Ohio.

See all family providers in Ohio

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin49$50,738
Trelegy ElliptaFluticasone/Umeclidin/Vilanter49$36,822
TrulicityDulaglutide18$26,087
OzempicSemaglutide20$24,614
MounjaroTirzepatide23$23,823
FarxigaDapagliflozin Propanediol33$23,772
EliquisApixaban25$19,995
XareltoRivaroxaban16$13,916
TradjentaLinagliptin25$13,145
Bydureon BciseExenatide Microspheres11$8,050
Emgality PenGalcanezumab-Gnlm11$7,287
Lantus SolostarInsulin Glargine,hum.Rec.Anlog11$2,484
Albuterol Sulfate HfaAlbuterol Sulfate81$1,847
Esomeprazole Magnesium23$1,745
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate11$1,533

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Tradjenta$239$63,88374 claims
Lilly USA, LLCTrulicity, Mounjaro$511$49,91041 claims
GSKTrelegy Ellipta$46$36,82249 claims
Novo NordiskOzempic$362$24,61420 claims
AstraZenecaFarxiga$361$23,77233 claims
PfizerEliquis$104$19,99525 claims
Johnson & JohnsonXarelto$155$13,91616 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 6,812 family providers in Ohio.

Other family in Wilmington

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →